PENUMBRA INC (PEN) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:PEN • US70975L1070

342.135 USD
+0.13 (+0.04%)
Last: Feb 6, 2026, 10:28 AM
Fundamental Rating

6

Taking everything into account, PEN scores 6 out of 10 in our fundamental rating. PEN was compared to 186 industry peers in the Health Care Equipment & Supplies industry. PEN has an excellent financial health rating, but there are some minor concerns on its profitability. PEN is growing strongly while it is still valued neutral. This is a good combination! These ratings could make PEN a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year PEN was profitable.
  • In the past year PEN had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PEN reported negative net income in multiple years.
  • In multiple years PEN reported negative operating cash flow during the last 5 years.
PEN Yearly Net Income VS EBIT VS OCF VS FCFPEN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

  • PEN has a better Return On Assets (9.40%) than 91.94% of its industry peers.
  • With an excellent Return On Equity value of 12.07%, PEN belongs to the best of the industry, outperforming 88.71% of the companies in the same industry.
  • PEN has a better Return On Invested Capital (7.37%) than 82.26% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PEN is significantly below the industry average of 8.80%.
  • The 3 year average ROIC (2.98%) for PEN is below the current ROIC(7.37%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROIC 7.37%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
PEN Yearly ROA, ROE, ROICPEN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

  • PEN has a Profit Margin of 12.30%. This is amongst the best in the industry. PEN outperforms 88.17% of its industry peers.
  • In the last couple of years the Profit Margin of PEN has declined.
  • PEN has a better Operating Margin (12.95%) than 80.65% of its industry peers.
  • PEN's Operating Margin has declined in the last couple of years.
  • PEN's Gross Margin of 66.80% is fine compared to the rest of the industry. PEN outperforms 71.51% of its industry peers.
  • In the last couple of years the Gross Margin of PEN has remained more or less at the same level.
Industry RankSector Rank
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
PEN Yearly Profit, Operating, Gross MarginsPEN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • PEN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, PEN has less shares outstanding
  • PEN has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, PEN has an improved debt to assets ratio.
PEN Yearly Shares OutstandingPEN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
PEN Yearly Total Debt VS Total AssetsPEN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

  • PEN has an Altman-Z score of 22.75. This indicates that PEN is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of PEN (22.75) is better than 96.77% of its industry peers.
  • PEN has a debt to FCF ratio of 0.15. This is a very positive value and a sign of high solvency as it would only need 0.15 years to pay back of all of its debts.
  • The Debt to FCF ratio of PEN (0.15) is better than 93.01% of its industry peers.
  • PEN has a Debt/Equity ratio of 0.02. This is a healthy value indicating a solid balance between debt and equity.
  • PEN has a better Debt to Equity ratio (0.02) than 72.04% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Altman-Z 22.75
ROIC/WACC0.72
WACC10.17%
PEN Yearly LT Debt VS Equity VS FCFPEN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • PEN has a Current Ratio of 6.73. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • PEN has a better Current ratio (6.73) than 85.48% of its industry peers.
  • PEN has a Quick Ratio of 4.18. This indicates that PEN is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.18, PEN is in the better half of the industry, outperforming 76.88% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.73
Quick Ratio 4.18
PEN Yearly Current Assets VS Current LiabilitesPEN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 36.47% over the past year.
  • PEN shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 24.23% yearly.
  • The Revenue has grown by 14.61% in the past year. This is quite good.
  • Measured over the past years, PEN shows a quite strong growth in Revenue. The Revenue has been growing by 16.89% on average per year.
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%

3.2 Future

  • PEN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.42% yearly.
  • PEN is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.24% yearly.
EPS Next Y32.98%
EPS Next 2Y33.42%
EPS Next 3Y31.48%
EPS Next 5Y24.42%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
PEN Yearly Revenue VS EstimatesPEN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
PEN Yearly EPS VS EstimatesPEN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • PEN is valuated quite expensively with a Price/Earnings ratio of 94.25.
  • 66.67% of the companies in the same industry are more expensive than PEN, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.67, PEN is valued quite expensively.
  • Based on the Price/Forward Earnings ratio of 66.97, the valuation of PEN can be described as expensive.
  • PEN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. PEN is cheaper than 67.20% of the companies in the same industry.
  • PEN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.20.
Industry RankSector Rank
PE 94.25
Fwd PE 66.97
PEN Price Earnings VS Forward Price EarningsPEN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, PEN is valued a bit cheaper than 65.05% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of PEN indicates a somewhat cheap valuation: PEN is cheaper than 69.89% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 87.79
EV/EBITDA 67.29
PEN Per share dataPEN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PEN does not grow enough to justify the current Price/Earnings ratio.
  • PEN has a very decent profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as PEN's earnings are expected to grow with 31.48% in the coming years.
PEG (NY)2.86
PEG (5Y)3.89
EPS Next 2Y33.42%
EPS Next 3Y31.48%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • PEN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PENUMBRA INC

NYSE:PEN (2/6/2026, 10:28:43 AM)

342.135

+0.13 (+0.04%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05
Earnings (Next)02-24
Inst Owners97.98%
Inst Owner Change-0.16%
Ins Owners3.7%
Ins Owner Change2.01%
Market Cap13.40B
Revenue(TTM)1.33B
Net Income(TTM)164.03M
Analysts85.83
Price Target342.61 (0.14%)
Short Float %4.59%
Short Ratio1.79
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.92%
Min EPS beat(2)3.63%
Max EPS beat(2)4.22%
EPS beat(4)4
Avg EPS beat(4)9.67%
Min EPS beat(4)3.63%
Max EPS beat(4)23.86%
EPS beat(8)8
Avg EPS beat(8)11.2%
EPS beat(12)12
Avg EPS beat(12)25.5%
EPS beat(16)14
Avg EPS beat(16)17.71%
Revenue beat(2)2
Avg Revenue beat(2)2.8%
Min Revenue beat(2)2.56%
Max Revenue beat(2)3.05%
Revenue beat(4)4
Avg Revenue beat(4)1.89%
Min Revenue beat(4)0.28%
Max Revenue beat(4)3.05%
Revenue beat(8)6
Avg Revenue beat(8)0.73%
Revenue beat(12)10
Avg Revenue beat(12)1.17%
Revenue beat(16)12
Avg Revenue beat(16)1.31%
PT rev (1m)1.25%
PT rev (3m)6.92%
EPS NQ rev (1m)1.57%
EPS NQ rev (3m)-0.34%
EPS NY rev (1m)0.28%
EPS NY rev (3m)1.09%
Revenue NQ rev (1m)1.32%
Revenue NQ rev (3m)1.39%
Revenue NY rev (1m)0.22%
Revenue NY rev (3m)1.3%
Valuation
Industry RankSector Rank
PE 94.25
Fwd PE 66.97
P/S 10.05
P/FCF 87.79
P/OCF 65.91
P/B 9.86
P/tB 11.3
EV/EBITDA 67.29
EPS(TTM)3.63
EY1.06%
EPS(NY)5.11
Fwd EY1.49%
FCF(TTM)3.9
FCFY1.14%
OCF(TTM)5.19
OCFY1.52%
SpS34.06
BVpS34.7
TBVpS30.28
PEG (NY)2.86
PEG (5Y)3.89
Graham Number53.23
Profitability
Industry RankSector Rank
ROA 9.4%
ROE 12.07%
ROCE 10.97%
ROIC 7.37%
ROICexc 10.5%
ROICexgc 12.46%
OM 12.95%
PM (TTM) 12.3%
GM 66.8%
FCFM 11.44%
ROA(3y)2.2%
ROA(5y)1.03%
ROE(3y)2.91%
ROE(5y)1.37%
ROIC(3y)2.98%
ROIC(5y)N/A
ROICexc(3y)3.84%
ROICexc(5y)N/A
ROICexgc(3y)4.75%
ROICexgc(5y)N/A
ROCE(3y)4.43%
ROCE(5y)N/A
ROICexgc growth 3Y49.31%
ROICexgc growth 5Y-5.8%
ROICexc growth 3Y58%
ROICexc growth 5Y-7.52%
OM growth 3Y43.4%
OM growth 5Y-3.62%
PM growth 3Y18.27%
PM growth 5Y-33.26%
GM growth 3Y-0.21%
GM growth 5Y-1.44%
F-Score7
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.15
Debt/EBITDA 0.11
Cap/Depr 291.22%
Cap/Sales 3.8%
Interest Coverage 250
Cash Conversion 106.89%
Profit Quality 93.05%
Current Ratio 6.73
Quick Ratio 4.18
Altman-Z 22.75
F-Score7
WACC10.17%
ROIC/WACC0.72
Cap/Depr(3y)74.85%
Cap/Depr(5y)109.14%
Cap/Sales(3y)1.83%
Cap/Sales(5y)2.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.47%
EPS 3Y60.05%
EPS 5Y24.23%
EPS Q2Q%14.12%
EPS Next Y32.98%
EPS Next 2Y33.42%
EPS Next 3Y31.48%
EPS Next 5Y24.42%
Revenue 1Y (TTM)14.61%
Revenue growth 3Y16.91%
Revenue growth 5Y16.89%
Sales Q2Q%17.82%
Revenue Next Year16.21%
Revenue Next 2Y15.29%
Revenue Next 3Y14.8%
Revenue Next 5Y13.24%
EBIT growth 1Y54.5%
EBIT growth 3Y67.65%
EBIT growth 5Y12.66%
EBIT Next Year80.23%
EBIT Next 3Y41.84%
EBIT Next 5Y26.5%
FCF growth 1Y222.8%
FCF growth 3YN/A
FCF growth 5Y100.55%
OCF growth 1Y225.73%
OCF growth 3Y160.78%
OCF growth 5Y44.6%

PENUMBRA INC / PEN FAQ

What is the ChartMill fundamental rating of PENUMBRA INC (PEN) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PEN.


What is the valuation status of PENUMBRA INC (PEN) stock?

ChartMill assigns a valuation rating of 4 / 10 to PENUMBRA INC (PEN). This can be considered as Fairly Valued.


Can you provide the profitability details for PENUMBRA INC?

PENUMBRA INC (PEN) has a profitability rating of 6 / 10.


Can you provide the expected EPS growth for PEN stock?

The Earnings per Share (EPS) of PENUMBRA INC (PEN) is expected to grow by 32.98% in the next year.